TWST Twist Bio: Net earnings per share growth forecast for next year
Twist Bioscience (TWST) has secured immense industry trust through its status as a DNA synthesis revolutionary, which is further validated by a promising valuation of net profit dynamics. Market dominance is sustained by a unique silicon-based printing process that creates significant pricing power. Simultaneously, this chip-based method radically reduces resource consumption, aligning with ESG principles. The value of 38.30 corresponds to the current analyst yield expectation metric.
TWST (twistbioscience.com): analytical breakdowns and indicator data
- share price and consensus valuation forecast:
- company stock capitalization data:
- company book value details:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Twist Bioscience|TWST - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Twist Bioscience, Inc.|TWST - Company Cumulative Debt|Debt to Book Capitalization Ratio Twist Bioscience|TWST - Company Long-Term Indebtedness|Company Short-Term Debts Twist Bioscience|Quick Ratio twistbioscience.com
- net income and valuation ratios data:
TWST - Company Net Income|Future Profit Twist Bioscience|TWST - Market Price to Net Income Ratio|Projected Price to Earnings Twist Bioscience|TWST - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Twist Bioscience|TWST - Operating income before deduction of amortization|Net earnings per share for the last 12 months Twist Bioscience|TWST - Earnings per share for the last four quarters|Quarterly EPS earnings growth twistbioscience.com|TWST - Earnings per share growth this year|Net earnings per share growth forecast for next year Twist Bioscience
Fundamental company analysis:TWST, Twist Bio
To find fundamental support for Twist Bioscience (TWST) assets, it is essential to analyze the forward earnings growth forecast, which reflects the analysts' consensus estimate for EPS changes in the coming year. This indicator measures the expected net income trend, allowing for an assessment of how explosive demand for synthetic DNA and ARR growth can reduce current losses and bring the company closer to the break-even point.
Competing companies
TEM (Tempus AI, Inc) - Earnings growth forecast for next year|Qiagen Corp (QGEN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Ionis Pharmaceuticals (IONS)|RGEN - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Avidity Biosciences, Inc. RNA|Consensus forecast of earnings per share growth for next year CRISPR Therapeutics Inc (CRSP)|Sema4 - Earnings growth forecast for next year|Ultragenyx Corp (RARE) - Expected earnings per share growth for next year|BEAM: Earnings growth forecast for next year|SRPT - Consensus forecast of earnings per share growth for next year|TXG (10x Genomics) - Earnings growth forecast for next year|Expected net earnings per share growth next year Intellia Therapeutics Inc NTLA|Net earnings per share growth forecast for next year Stoke (STOK)|BioLife - Projected earnings per share growth rate for next year|Earnings growth forecast for next year WVE (Wave Life Sciences)|MAZE - Expected earnings per share growth for next year|Sionna Therapeutics - Earnings growth forecast for next year|Expected net earnings per share growth next year Prime Medicine Inc|TSHA (Taysha) - Expected earnings per share growth for next year|QURE: Projected earnings per share increase next year|Expected earnings per share growth for next year MGTX|Expected earnings per share growth for next year regenxbio.com (RGNX)|Net earnings per share growth forecast for next year Solid Biosciences (SLDB)|Consensus forecast of earnings per share growth for next year Ocugen Inc|Pacific Biosciences of California - Expected earnings per share growth for next year|Projected earnings per share increase next year BNTC (Benitec Corp)|Design Therapeutics - Earnings growth forecast for next year|RCKT (rocketpharma.com) - Projected earnings per share growth rate for next year|4D Molecular Therapeutics, Inc. (FDMT) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year LXEO|KRRO (Korro Bio Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Editas Corp|Expected earnings per share growth for next year SLN (Silence Therapeutics)|Projected earnings per share increase next year PRQR|Codexis - Expected earnings per share growth for next year|SGMO - Expected earnings per share growth for next year|Nautilus Biotechnology Inc - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Metagenomi Therapeutics MGX|Precision BioSciences, Inc. (DTIL) - Net earnings per share growth forecast for next year|GBIO - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year BOLD|XCUR (Exicure Corp) - Projected earnings per share increase next year|Expected earnings per share growth for next year IMNN (Imunon, Inc.)|PHIO (phiopharma.com) - Expected earnings per share trend next year|Earnings growth forecast for next year MBIO (Mustang Bio)|TransCode Therapeutics Inc. - Net earnings per share growth forecast for next year|Bionano - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Applied DNA Sciences Inc APDN|Bluebird Bio (BLUE) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year ImmunoPrecise Antibodies Ltd. (IPA)|Net earnings per share growth forecast for next year Omega Therapeutics|singulargenomics.com (OMIC) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year RGLS|Expected earnings per share growth for next year Syros Pharmaceuticals Inc. SYRS|Earnings growth forecast for next year TBIO (Codex DNA)|Consensus forecast of earnings per share growth for next year TRACON Pharmaceuticals, Inc (TCON)|Unity Biotechnology - Earnings growth forecast for next year
